Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. [electronic resource]
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology Oct 2005
- 1592-601 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
1530-6860
10.1096/fj.04-3620rev doi
Aged Aged, 80 and over Alzheimer Disease--drug therapy Animals Animals, Genetically Modified Anti-Inflammatory Agents, Non-Steroidal--therapeutic use Cell Culture Techniques Cyclooxygenase Inhibitors--therapeutic use Disease Models, Animal Enzyme-Linked Immunosorbent Assay Flurbiprofen--therapeutic use Humans Ibuprofen--therapeutic use Indomethacin--therapeutic use Inflammation Models, Biological Models, Chemical Models, Genetic NF-kappa B--metabolism PPAR gamma--metabolism Peptides--chemistry Peroxisome Proliferator-Activated Receptors--metabolism Prostaglandin-Endoperoxide Synthases--metabolism